PRSS50 and colorectal carcinoma: Antibodies used for immunohistochemistry can detect both the wild-type and the mutated p53 protein, and TSP50 expression is significantly higher in breast cancer cells in which p53 gene is mutated [4], so TSP50 expression might be correlated with the status of p53 gene but not with the accumulated quantity of p53 protein in CRC.